APAR INDUSTRIES LTD.

621.25 +0.35 (+0.06%) Buy

APARINDS continues it's uptrend, although on a weaker note

13 min read

APARINDS managed to marginally outperform the broader market today. On a longer term basis, investors in APAR INDUSTRIES LTD. made +0.11% per day. Friday's performance of +0.06% was a significant outperformance compared to it's daily average.

[Themes containing APARINDS]

Buy-and-Hold investors in APARINDS experienced a maximum drawdown of -7.48% over the last three months. It gained +10.41% during this strong up trending period. There were both Long and Short signals during this period, while the long signals were significantly more profitable than the short signals. The net profit from Long signals was +4.41%.

Trend

APARINDS has been underperforming the NIFTY-50 index in recent time, after having outperformed till 31 May, 2017. Over the last 3 years and 1 month, APARINDS underperformed the NIFTY-50 index on 51% days.

APARINDS was profitable on 52% days in the last three months. During this time, it delivered on average +0.17% per day. It delivered it's best daily return of +4.99%, during this period, on Monday, 17 Dec, 2018. There was initially a bullish trend during this period which started on 2 Nov, 2018 and went on till 15 Nov, 2018. The bullish trend returned +14.36% to investors. This was followed by a bearish trend that started on 2 Jan, 2019 and ended on 11 Jan, 2019. This bearish trend lost -7.72% of investor capital.

On monthly basis, APARINDS delivered losses in more months over the last year, than profits. APARINDS delivered profits less regularly than NIFTY-50 index. APARINDS was also a more risky investment than NIFTY-50 index as it's worst month in the last year, May 2018, returned -12.77% compared to -6.42% returned by NIFTY-50 index in Sep 2018. APARINDS had a longer winning streak of losing months than NIFTY-50 index. It went down in 3 straight months (from May 2018 to Jul 2018) during which period it delivered -23.05%.

If you don't value your time, neither will others. Stop giving away your time and talents. Value what you know & start charging for it.
-- Kim Garst

APARINDS is becoming less volatile overall. In comparison, the NIFTY-50 index is seeing a fall in volatility. During the last three months, there was a significant fall in APARINDS's volatility from 19 Nov, 2018 to 4 Dec, 2018. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that APARINDS has negative skewness in it's return distribution. This indicates that investors may need to stay invested through long periods of drawdown before expecting a recovery.

NIFTY-50 index has more chance of extreme outcomes than APARINDS. Therefore, NIFTY-50 must receive a lower allocation than APARINDS in your portfolio. NIFTY-50 index usually has shorter drawdown period than APARINDS.

On a general note (since you are interested in APARINDS), two instruments that have been extremely volatile in recent times are HATSUN and TIDEWATER. Investors in these instruments should consider reducing their exposure (to HATSUN and TIDEWATER) and diversifying their portfolios.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter